Drug Shortage Report for SUPEUDOL 5
Report ID | 135633 |
Drug Identification Number | 00789739 |
Brand name | SUPEUDOL 5 |
Common or Proper name | SUPEUDOL 5 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | OXYCODONE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100TAB BO V1 CA |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2021-03-12 |
Estimated end date | 2021-03-26 |
Actual end date | 2021-03-29 |
Shortage status | Resolved |
Updated date | 2021-03-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-03-30 | English | Compare |
v4 | 2021-03-29 | French | Compare |
v3 | 2021-03-29 | English | Compare |
v2 | 2021-03-15 | French | Compare |
v1 | 2021-03-15 | English | Compare |
Showing 1 to 5 of 5